Clinical Trial: A Phase I Study of LY3502970 in Healthy Participants
Study Status: NOT_YET_RECRUITING
Recruit Status: NOT_YET_RECRUITING
Condition: Healthy
Study Type: INTERVENTIONAL
Official Title: A Single-Group, Open-Label, Single-Period, Phase 1 Study to Determine the Absolute Bioavailability of LY3502970 in Healthy Participants
Brief Summary:
The main purpose of this study is to evaluate how much of the study drug (LY3502970) and the radioactive substance 14C incorporated LY3502970 gets into the bloodstream, how its broken down, and how long it takes the body to get rid of it.The study will last up to approximately 9 weeks for each participant.
Read more